Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 30, Amgen Inc.
Keep Reading →
July 6 - News
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy.
Keep Reading →
July 4 - News
On July 3rd, Dan Ives, Global Head of Tech Research at Wedbush, joined CNBC to discuss the technology sector.
Keep Reading →
July 3 - Hedge Funds, News
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires.
Keep Reading →
July 3 - News
The H1 2025 has been a roller coaster ride for the investors.
Keep Reading →
July 2 - Hedge Funds, News
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest...
Keep Reading →
June 30 - Hedge Funds, News
On Wednesday’s episode of Mad Money, host Jim Cramer shared his thoughts on the notion of whether the current surge in semiconductor stocks could be the modern-day equivalent...
Keep Reading →
June 27 - Hedge Funds, News
Amgen Inc. (NASDAQ:AMGN) is one of the 15 best stocks to invest in for an 18 year old. Amgen Inc.
Keep Reading →
June 17 - News
The company has built a solid track record of dividend growth, supported by consistent cash generation.
Keep Reading →
June 16 - News
The next generation of dividend aristocrats can often be spotted through their consistent dividend growth, solid starting yields, and overall stability, even if they haven’t...
Keep Reading →
June 16 - Hedge Funds, News
Amgen Inc. (NASDAQ:AMGN) is one of the 11 most profitable NASDAQ stocks to buy now.
Keep Reading →
June 15 - News
Earlier on May 30, Siebert Financial CIO Mark Malek appeared on CNBC to discuss the tariff headwinds swirling around the markets and which sectors could then rise above the noise...
Keep Reading →
June 13 - News
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Keep Reading →
June 12 - Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.
Keep Reading →
May 7 - News, Stock Analysis
The Dow Jones Industrial Average is a benchmark index of the top 30 companies in the US.
Keep Reading →
May 7 - News, Stock Analysis
Operator: My name is Julianne and I'll be your conference facilitator today for the Amgen Q1 FY 2025 Earnings Conference Call.
Keep Reading →
May 2 - News, Transcripts
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
Keep Reading →
April 30 - Hedge Funds, Industries, News
On April 10, Dan Ives, Head of Global Tech Research at Wedbush Securities, appeared on an interview at CNBC and expressed that the tech sector could be heading into a period of...
Keep Reading →
April 21 - Hedge Funds, News
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
Keep Reading →
April 16 - Hedge Funds, News
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Keep Reading →
March 20 - Dividend Stocks, Hedge Funds, News
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Keep Reading →
March 15 - Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
The Dobermans of the Dow strategy serves as an alternative to the well-known Dogs of the Dow approach, offering a more selective screening process.
Keep Reading →
March 10 - Dividend Stocks, Hedge Funds, News
On March 5th, BBC reported that the US stock market had fallen after the tariffs sparked trade war fear.
Keep Reading →
March 4 - Hedge Funds, News
In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in...
Keep Reading →
February 27 - Hedge Funds, News
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of...
Keep Reading →
February 25 - Hedge Funds, Industries, News
After much suspense, the US Federal Reserve finally began cutting interest rates in late 2024, dropping the federal funds rate by 75 basis points in two cuts in September and ...
Keep Reading →
February 25 - Hedge Funds, News, Retirement
The Dow is a renowned and significant stock market index that measures the performance of 30 publicly traded businesses listed on US stock exchanges, representing a diverse variety...
Keep Reading →
February 22 - Hedge Funds, News
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development...
Keep Reading →
February 22 - Hedge Funds, News
We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.
Keep Reading →
February 17 - News, Stock Analysis
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
On Thursday, Jim Cramer, the host of Mad Money, drew attention to ten stocks that have been driving the performance of the Dow Jones Industrial Average in 2025.
Keep Reading →
February 7 - Hedge Funds, News
Operator: My name is Julienne, and I will be your conference facilitator today for Amgen's Fourth Quarter and Full Year 2024 Financial Results Conference Call.
Keep Reading →
February 6 - News, Transcripts
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
Keep Reading →
February 2 - Hedge Funds, News
Growth stocks are typically seen as companies with the potential to outperform the market in the future, even if they are currently unprofitable or trading at high valuations.
Keep Reading →
January 30 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN.
Keep Reading →
January 20 - News, Stock Analysis
The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential cooling in inflation pressures.
Keep Reading →
January 18 - Hedge Funds, News
Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to stock selection and his long-standing track record...
Keep Reading →
January 18 - Hedge Funds, News
The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.
Keep Reading →
January 16 - Dividend Stocks, Hedge Funds, News
The NASDAQ, heavily comprised of technology stocks, has been on a consistent upward trajectory for some years.
Keep Reading →
January 16 - Dividend Stocks, Hedge Funds, News
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
Dividend-focused investors are often drawn to stocks with high yields, shaping their strategies around acquiring such investments.
Keep Reading →
December 17 - Dividend Stocks, Hedge Funds, News
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Keep Reading →
December 14 - Hedge Funds, News
Statistically, November and December tend to be great months for stocks.
Keep Reading →
December 11 - Hedge Funds, News
There has been a growing debate regarding whether the economy of the United States will have a soft landing.
Keep Reading →
December 5 - Hedge Funds, News
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN.
Keep Reading →
November 30 - News, Stock Analysis
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Keep Reading →
November 18 - Hedge Funds, News